Brown’s Compounding Center, a Colorado pharmacy that creates customized prescription medications to meet individual patients’ needs, recently hosted the ribbon-cutting ceremony for its brand-new, state-of-the-art lab near Denver. The 38,000-square-foot facility, one of the largest of its kind in the country, will serve as the U.S. headquarters for Brown’s, which serves patients in 38 states and counting.

 

“For the last 10 years, Brown’s has proudly served patients across the country from our home here in Colorado,” says Darby Brown, founder and CEO of Brown’s Compounding Center. “This new facility will enable us to meet the growing demand for prescription medications tailored specifically to individual patients’ needs, while maintaining our strict standards for safety, quality and patient care.”

 

Several state dignitaries attended and spoke at the grand opening ceremony, including Secretary of State Scott Gessler and U.S. Rep. Mike Coffman (R, 6th District).

 

One of the highlights of the new facility is its $2 million cleanroom, a world-class, 7,000-square-foot aseptic lab for production of sterile medications. Brown’s adheres to comprehensive safety standards for all medications produced in its lab, including frequent, meticulous quality testing. The new facility draws 100 percent of its energy needs from solar power, enabling the lab to continue operations uninterrupted — even in the event of local power outages.

 

Brown’s current staff of 95 employees, including licensed pharmacists, pharmacy technicians, customer care representatives and support staff, is expected to nearly triple in the new facility, which is nearly 10 times larger than Brown’s previous facility in nearby Parker, Colo. The new facility will allow Brown’s to expand its capabilities and continue to meet rigorous safety and cleanliness standards that exceed industry norms.

 

Doctors and patients across the country turn to Brown’s to address a wide variety of prescription needs, including pain management and sports medicine, hormone therapy, pediatric medications, adrenal and thyroid dysfunction, dermatology, ophthalmology and podiatry, among many others. Compound medications are tailored to meet individual patients’ needs that can’t be met by the commercial pharmaceuticals market.

 

Release Date: March 18,2014

Source: Brown’s Compounding Center